810220 | C6-NBD Galactosyl Ceramide
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1'-sphingosine
Info
C6-NBD Galactosyl Ceramide
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1'-sphingosine
Data
Yes
Yes
C36H59N5O11
C 58.60%, H 8.06%, N 9.49%, O 23.85%
>99%
1 Year
-20°C
CAS Number
170212-26-7
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
737.881
737.421
References
Ben-David O, Pewzner-Jung Y, Brenner O, Laviad EL, Kogot-Levin A, Weissberg I, Biton IE, Pienik R, Wang E, Kelly S, Alroy J, Raas-Rothschild A, Friedman A, Brügger B, Merrill AH Jr, Futerman AH. Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels. J Biol Chem. 2011 Aug 26;286(34):30022-33. doi: 10.1074/jbc.M111.261206. Epub 2011 Jun 24. PMID: 21705317; PMCID: PMC3191043.
PubMed ID: 21705317
Certificates of Analysis
- Certificate of Analysis (Lot No. 810220C-250UG-A-012 and 5391CEA012)
- Certificate of Analysis (Lot No. 810220P-250UG-A-012 and 5391PEA012)
- Certificate of Analysis (Lot No. 810220C-250UG-B-012 and 5391CEB012)
- Certificate of Analysis (Lot No. 810220P-250UG-B-012 and 5391PEB012)